Cytotoxic Effect of Thymoquinone-Loaded Nanostructured Lipid Carrier (TQ-NLC) on Liver Cancer Cell Integrated with Hepatitis B Genome, Hep3B

Figure 3

Caspase-7 expression in Hep3B upon treatment with TQ or TQ-NLC. (a) Western blot analysis of caspase-7 protein expression after treatment with indicated concentrations of TQ or TQ-NLC for 12, 24, 48, and 72 hours. Whole cell protein lysates were analyzed via Western blotting using antibodies against caspase-7. (b) Protein level was quantified using the densitometry analysis of Image J and expressed as relative density percentage. Data are presented as mean ± SEM and represent three independent experiments. Statistically significant differences are indicated as p<0.05. Note: compared with control; +compared between TQ and TQ-NLC.

(a)

(b)